about
[Pathogenesis of choroidal neovascularization. Old concepts, new questions][Diabetic maculopathy - classification and therapy].The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.Effect of 308 nm excimer laser irradiation on retinal pigment epithelium cell viability in vitro.Lipid peroxidation products reduce lysosomal protease activities in human retinal pigment epithelial cells via two different mechanisms of action.[Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].[Current therapeutic options in retinopathy of prematurity].Astrocyte pVHL and HIF-α isoforms are required for embryonic-to-adult vascular transition in the eyeGeneration of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells.Using flow cytometry to compare the dynamics of photoreceptor outer segment phagocytosis in iPS-derived RPE cellsNew pharmacologic approaches to therapy for age-related macular degeneration.In-depth mass spectrometric mapping of the human vitreous proteomeLipid metabolites in the pathogenesis and treatment of neovascular eye disease.Stemming vision loss with stem cells.Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative DamageEffects of lipid peroxidation products on lipofuscinogenesis and autophagy in human retinal pigment epithelial cells.Apical-to-basolateral transcytosis of photoreceptor outer segments induced by lipid peroxidation products in human retinal pigment epithelial cells.Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro.Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina.Light induces NLRP3 inflammasome activation in retinal pigment epithelial cells via lipofuscin-mediated photooxidative damage.[Unilateral blurred vision associated with combined macular and papillary edema: a 34-year-old male patient].[Juvenile neuronal ceroid lipofuscinosis. Ophthalmologic findings and differential diagnosis].[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists: endophthalmitis prophylaxis intravitreal operative medications input (IVOM) (July 2013)].[Diabetic retinopathy. Pathophysiology and therapy of hypoxia-induced inflammation].Mouse alpha-fetoprotein-specific DNA-based immunotherapy of hepatocellular carcinoma leads to tumor regression in mice.[Pathogenesis of diabetic macular oedema].Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization.Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans.[Unilateral visual impairment in the presence of retinal hemorrhages in a 35-year old female patient].Pharmacokinetics and safety of intravitreally delivered etanercept.Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.Inflammasome priming increases retinal pigment epithelial cell susceptibility to lipofuscin phototoxicity by changing the cell death mechanism from apoptosis to pyroptosis.Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice.Modulation of three key innate immune pathways for the most common retinal degenerative diseasesPlasmapheresis for Dry Age-Related Macular Degeneration—Evidence Based?Klassifikation biomedizinischer Forschungsberichte als Grundlage evidenzbasierter Medizin in der AugenheilkundeNo Evidence to Support the Use of Plasmapheresis for Age-Related Macular DegenerationOptical coherence tomography angiography (OCT-A) in an animal model of laser-induced choroidal neovascularizationEfficacy of novel selective NLRP3 inhibitors in human and murine retinal pigment epithelial cells
P50
Q30912597-A7E6D7B3-81A5-465E-A4E0-5C7D4FE70846Q30979687-442B69F4-62DB-4D28-A5EC-4872830C1E10Q31097437-1BCA7317-81D9-490A-82B9-B0AE5D6BE7B4Q33379517-31B6311A-EE5A-4A16-BDB7-252B34E1E0BAQ33515441-480DE005-17FE-4F71-A2BC-1AB4528B7423Q34409338-81FCAF52-12A5-4E4F-822D-23A1D78703E7Q34501395-FB6D8D0B-DF75-418D-B9EE-D38EADCB6B9BQ35670643-F467F011-A074-41F2-BAA9-A5BC71C06180Q35894518-B9AFF4C1-4669-4A8B-8C66-D23E597ACB9EQ36239454-1384423E-D759-42A4-BEB1-7FD52E6633D5Q36489172-B3B0FC5C-9BF7-4B4E-839A-56E924E1B782Q36946995-75C9B3F4-99B8-4403-B693-4CE75D142516Q37011339-DECC75C6-879B-484F-B5EE-C48D05D1D710Q37784659-BBE3C06D-C793-485C-99BC-5657F095D1F3Q38819720-A83C39DD-4866-41C4-AA4C-44D278174138Q39754366-DA09724F-2F0D-4E7E-AC6C-201ECACEA901Q39810141-98C71429-FE0A-4F55-899E-FF3A0C8F56D3Q40783189-4BF60976-99BD-4D54-9A16-8AE7FF3F694BQ41457604-5D7B28E1-7C41-4E7F-9792-6C3D4D7D2B22Q41851269-464E6A2A-42F1-4624-8ED0-42859886998FQ42835992-29D9189F-960B-4471-B47E-BBF93669B782Q43068342-5168376A-4FD0-4F1A-8615-5CE71A115CF3Q44167891-1CE69906-8A55-4D75-BA6F-B2C73E6666E0Q44442144-902AC4FE-5271-4FD5-8606-3D4A669E716EQ44470273-90B1AD1A-6693-42B5-911F-FC48A91AAA15Q44571787-67408992-E9EF-44F1-8104-2B8E84EA9D1CQ45865909-6DE97ABC-09DF-4DE9-91D2-B5F58E2FCB82Q45989684-FDF13EBB-1330-4104-900A-DDFA74125B37Q46478081-02356DE6-35B1-448B-9E9B-5503CB39A145Q46549659-18390CAE-4954-4F1B-8A98-3A200620213CQ47929172-2D1B2390-19C8-4711-8D58-0BEAEB87BC2EQ49112741-7426E15D-2B31-4286-BE72-9FC4E28751B6Q50201544-E9EB3BB8-B4BF-4F01-85F2-CFDBA9DD8BCBQ54574380-F3FCF98A-46C7-4471-A7F8-45EDC415224DQ58728893-6D1BB715-2D78-421E-8CEF-942B2E39464DQ61446035-94E01536-D347-48DC-94E7-B9537E7DC613Q61446062-C6458354-DA44-4FCF-B136-425E177AD3D8Q61910968-E8EC99D1-D7CB-4D49-90E8-1E51D0FEE119Q63384549-A8B1EB68-0C73-4098-84D2-2A21D82B4A29Q63384550-2BEA4F54-B82C-4674-90B9-84FFB6DA3259
P50
description
hulumtues
@sq
oogarts
@nl
researcher
@en
ricercatore
@it
taighdeoir
@ga
հետազոտող
@hy
name
Tim U. Krohne
@ast
Tim U. Krohne
@en
Tim U. Krohne
@es
Tim U. Krohne
@sl
type
label
Tim U. Krohne
@ast
Tim U. Krohne
@en
Tim U. Krohne
@es
Tim U. Krohne
@sl
altLabel
T Krohne
@en
T U Krohne
@en
Tim U Krohne
@en
Tim U. Krohne
@en
prefLabel
Tim U. Krohne
@ast
Tim U. Krohne
@en
Tim U. Krohne
@es
Tim U. Krohne
@sl
P214
P227
P1053
D-1497-2013
P1153
6602340737
P19
P21
P213
0000 0000 1549 4059
P214
P227
P31
P3829
P496
0000-0003-2280-925X
P569
1974-01-01T00:00:00Z
P735
P7859
viaf-8303778